BREAKING
Home » Archive by Category "Vaccines" (Page 46)

Canada survey: 70 percent for mandatory vaccinations, 29 percent say science isn’t ‘quite clear’

By

While the debate of mandatory vaccinations has crept its way back into British Columbia politics in light of the ongoing measles outbreak in Vancouver, at least one-fifth of Canadians in a recent survey...

2019-2020 northern hemisphere flu vaccine: Recommendation for the A(H3N2) component has been postponed

By

Twice annually, the World Health Organization (WHO) organizes consultations with an advisory group of experts to analyse influenza virus surveillance data generated by the WHO Global Influenza Surveillance...

Mayaro virus DNA vaccine induces protective immunity

By

A novel, synthetic DNA vaccine developed at The Wistar Institute induces protective immunity against Mayaro virus (MAYV), a mosquito-borne infection endemic to South America, that has the potential to...

generic influenza virion

Universal influenza vaccine: Oxford and Blue Water Vaccines enter agreement

By

Oxford University, through its innovation arm Oxford University Innovation (OUI), has entered into an option agreement for a universal influenza vaccine with US-based startup Blue Water Vaccines (BWV),...

Using the chickenpox virus to develop a vaccine against HIV

By

A study led by a University of Manitoba researcher has brought science one step closer to using the chickenpox virus to develop a vaccine against HIV. “Varicella-zoster virus, which causes chickenpox,...

pneumococcus

Merck’s 15-valent pneumococcal conjugate vaccine receives Breakthrough Therapy Designation

By

Merck announced this week that V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration...

Lyme Disease Vaccine Candidate: Valneva reports positive initial booster data and final Phase 1 data

By

Biotech company, Valneva SE, announced today positive initial booster data and final Phase 1 data for its leading, unique Lyme disease vaccine candidate VLA15. To investigate whether a VLA15 booster...

Dengue vaccine candidate proves efficacious in preventing any of the four serotypes of the virus

By

Takeda Pharmaceutical Company Limited today announced that the pivotal Phase 3 trial of its dengue vaccine candidate met the primary efficacy endpoint. This first analysis of the Tetravalent Immunization...

Malaysia health officials battle anti-vaccine propaganda

By

The Malaysian Ministry of Health reports there is much anti-vaccine propaganda on social media, which is influencing the public to reject life-saving vaccinations based on bad information. The Ministry...

Measles vaccination campaign continues in Costa Rica

By

The Ministry of Health reports the measles vaccination campaign in the country has completed its fourth week and  63% of the vaccines had been administered as of Jan. 11. The country is carrying out...